APA (7th ed.) Citation

K, R., FO, N., K, P., J, O., R, E., C, G., . . . Investigators, E. S. (2005). Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial. Lancet, 366(9494), 1367. https://doi.org/10.1016/s0140-6736(05)67566-6

Chicago Style (17th ed.) Citation

K, Reich, et al. "Infliximab Induction and Maintenance Therapy for Moderate-to-severe Psoriasis: A Phase III, Multicentre, Double-blind Trial." Lancet 366, no. 9494 (2005): 1367. https://doi.org/10.1016/s0140-6736(05)67566-6.

MLA (9th ed.) Citation

K, Reich, et al. "Infliximab Induction and Maintenance Therapy for Moderate-to-severe Psoriasis: A Phase III, Multicentre, Double-blind Trial." Lancet, vol. 366, no. 9494, 2005, p. 1367, https://doi.org/10.1016/s0140-6736(05)67566-6.